TET2 and myeloproliferative neoplasm: Mutations in TET2 may be an early phenomenon as they are found in approximately 20% of preleukaemic conditions such as MDS (myelodysplastic syndrome) and MPN (myeloproliferative neoplasms) [42, 43].